Average household exposure to newspaper coverage about the harmful effects of hormone therapy and population-based declines in hormone therapy use
- PMID: 17351842
- PMCID: PMC1824785
- DOI: 10.1007/s11606-007-0122-7
Average household exposure to newspaper coverage about the harmful effects of hormone therapy and population-based declines in hormone therapy use
Abstract
Background: The news media facilitated the rapid dissemination of the findings from the estrogen plus progestin therapy arm of the Women's Health Initiative (EPT-WHI).
Objective: To examine the relationship between the potential exposure to newspaper coverage and subsequent hormone therapy (HT) use. DESIGN/POPULATION: Population-based cohort of women receiving mammography at 7 sites (327,144 postmenopausal women).
Measurements: The outcome was the monthly prevalence of self-reported HT use. Circulation data for local, regional, and national newspapers was used to create zip-code level measures of the estimated average household exposure to newspaper coverage that reported the harmful effects of HT in July 2002.
Results: Women had an average potential household exposure of 1.4 articles. There was substantial variation in the level of average household exposure to newspaper coverage; women from rural sites received less than women from urban sites. Use of HT declined for all average potential exposure groups after the publication of the EPT-WHI. HT prevalence among women who lived in areas where there was an average household exposure of at least 3 articles declined significantly more (45 to 27%) compared to women who lived in areas with <1 article (43 to 31%) during each of the subsequent 5 months (relative risks 0.86-0.92; p < .006 for all).
Conclusions: Greater average household exposure to newspaper coverage about the harms associated with HT was associated with a large population-based decline in HT use. Further studies should examine whether media coverage directly influences the health behavior of individual women.
Figures
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.288.3.321', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.288.3.321'}, {'type': 'PubMed', 'value': '12117397', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12117397/'}]}
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '14757616', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/14757616/'}]}
- Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy with the publication of clinical trial results. Ann Intern Med. 2004;140(3):184–8. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.291.1.47', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.291.1.47'}, {'type': 'PubMed', 'value': '14709575', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/14709575/'}]}
- Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004;291(1):47–53. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15516400', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15516400/'}]}
- Buist DS, Newton KM, Miglioretti DL, et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol. 2004;104(5 Pt 1):1042–50. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '1891034', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/1891034/'}]}
- Phillips DP, Kanter EJ, Bednarczyk B, Tastad PL. Importance of the lay press in the transmission of medical knowledge to the scientific community. N Engl J Med. 1991;325(16):1180–3. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 CA080888/CA/NCI NIH HHS/United States
- U01 CA063740/CA/NCI NIH HHS/United States
- U01CA69976/CA/NCI NIH HHS/United States
- U01 CA070040/CA/NCI NIH HHS/United States
- U01CA70013/CA/NCI NIH HHS/United States
- U01 CA086082/CA/NCI NIH HHS/United States
- U01CA63736/CA/NCI NIH HHS/United States
- U01CA86082/CA/NCI NIH HHS/United States
- U01CA70040/CA/NCI NIH HHS/United States
- U01CA63740/CA/NCI NIH HHS/United States
- U01 CA063731/CA/NCI NIH HHS/United States
- U01 CA086076/CA/NCI NIH HHS/United States
- U01 CA069976/CA/NCI NIH HHS/United States
- U01CA86076/CA/NCI NIH HHS/United States
- U01 CA063736/CA/NCI NIH HHS/United States
- U01 CA070013/CA/NCI NIH HHS/United States
- U01CA63731/CA/NCI NIH HHS/United States
